Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 584
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04042506 | SBRT as a Vaccination for Metastatic Melanoma | ||
| NCT00047242 | UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors | ||
| NCT02120157 | Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies | ||
| NCT02825875 | Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer | ||
| NCT00253669 | Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas | ||
| NCT06398457 | Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies | ||
| NCT00025675 | Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors | ||
| NCT04589247 | Improving Cancer On-treatment Symptom Management | ||
| NCT03793543 | Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer | ||
| NCT04465643 | Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor | ||
| NCT06205836 | Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer | ||
| NCT01372202 | CHFR Methylation Status Esophageal Cancer Study | ||
| NCT00276601 | Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia | ||
| NCT00010049 | Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma | ||
| NCT00293410 | Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders | ||
| NCT00245115 | Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia | ||
| NCT03091478 | Pembrolizumab in Patients With Leptomeningeal Disease | ||
| NCT00267332 | Modafinil in Opioid Induced Sedation | ||
| NCT03971734 | Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas | ||
| NCT00559429 | Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer | ||
| NCT00971737 | Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer | ||
| NCT00002778 | Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | ||
| NCT02396368 | A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer | ||
| NCT04171440 | Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy | ||
| NCT02146937 | A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance | ||
| NCT01417182 | Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer | ||
| NCT01118741 | Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA) | ||
| NCT01478854 | Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide | ||
| NCT00077558 | 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome | ||
| NCT04926168 | 6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM) | ||
| NCT01439217 | Endothelial Function, Arterial Stiffness and Components | ||
| NCT02485990 | Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma) | ||
| NCT00796562 | Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy | ||
| NCT01861340 | Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma | ||
| NCT02431676 | Survivorship Promotion In Reducing IGF-1 Trial | ||
| NCT01607008 | MRI for Assessing Prostate Cancer Response | ||
| NCT01966289 | SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) | ||
| NCT00949325 | Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma | ||
| NCT00005878 | Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus | ||
| NCT02575222 | Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma | ||
| NCT00276588 | Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT06463262 | Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma | ||
| NCT01480050 | Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma | ||
| NCT00484874 | Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma | ||
| NCT03246074 | Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer | ||
| NCT02716974 | A Study of Definitive Therapy to Treat Prostate Cancer | ||
| NCT06245889 | PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC | ||
| NCT01729260 | Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide | ||
| NCT00003751 | Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma | ||
| NCT00003961 | Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome |
